Launching Your Own Line

We are committed to providing patients with cutting-edge solutions and expanding the possibilities for effective treatment and improved quality of life.

Confronting the Cancer Crisis: Genygi’s Commitment to Innovation and Patient Care

In 2024, there were approximately 20 million new cancer cases and 9.7 million cancer deaths worldwide (WHO data). The incidence of cancer continues to rise due to an aging and growing population.

By 2040, the number of new cancer cases worldwide is projected to increase by 77%, reaching 28.4 million per year. Cancer is a leading cause of death, claiming nearly 10 million lives annually (WHO data).

According to the WHO (2022), the most common cancers are lung cancer (12.4%), breast cancer (12%), colorectal cancer (9.6%), prostate cancer (7.3%), and stomach cancer (4.9%) of all new cases.

Given the success of Genygi’s research efforts, the introduction of new drugs to the market is expected in the near future.

Early diagnosis and effective treatment are crucial for improving cancer outcomes. Regular checkups and a healthy lifestyle help to reduce the risk of developing cancer.